rs3798756

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.22671C>T​(p.Ile7557=) variant causes a synonymous change. The variant allele was found at a frequency of 0.137 in 1,613,848 control chromosomes in the GnomAD database, including 15,985 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1518 hom., cov: 32)
Exomes 𝑓: 0.14 ( 14467 hom. )

Consequence

SYNE1
NM_182961.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 4.31
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 6-152208125-G-A is Benign according to our data. Variant chr6-152208125-G-A is described in ClinVar as [Benign]. Clinvar id is 130423.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152208125-G-A is described in Lovd as [Likely_benign]. Variant chr6-152208125-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.22671C>T p.Ile7557= synonymous_variant 125/146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.22671C>T p.Ile7557= synonymous_variant 125/1461 NM_182961.4 ENSP00000356224 P1Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.136
AC:
20594
AN:
151910
Hom.:
1516
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.150
Gnomad AMR
AF:
0.189
Gnomad ASJ
AF:
0.144
Gnomad EAS
AF:
0.222
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.0848
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.132
Gnomad OTH
AF:
0.145
GnomAD3 exomes
AF:
0.145
AC:
36453
AN:
251110
Hom.:
2997
AF XY:
0.144
AC XY:
19561
AN XY:
135696
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.200
Gnomad ASJ exome
AF:
0.137
Gnomad EAS exome
AF:
0.220
Gnomad SAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.0845
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.152
GnomAD4 exome
AF:
0.137
AC:
199824
AN:
1461820
Hom.:
14467
Cov.:
33
AF XY:
0.137
AC XY:
99691
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.120
Gnomad4 AMR exome
AF:
0.202
Gnomad4 ASJ exome
AF:
0.136
Gnomad4 EAS exome
AF:
0.235
Gnomad4 SAS exome
AF:
0.150
Gnomad4 FIN exome
AF:
0.0862
Gnomad4 NFE exome
AF:
0.132
Gnomad4 OTH exome
AF:
0.143
GnomAD4 genome
AF:
0.136
AC:
20613
AN:
152028
Hom.:
1518
Cov.:
32
AF XY:
0.135
AC XY:
10009
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.121
Gnomad4 AMR
AF:
0.190
Gnomad4 ASJ
AF:
0.144
Gnomad4 EAS
AF:
0.222
Gnomad4 SAS
AF:
0.149
Gnomad4 FIN
AF:
0.0848
Gnomad4 NFE
AF:
0.132
Gnomad4 OTH
AF:
0.147
Alfa
AF:
0.136
Hom.:
2462
Bravo
AF:
0.145
Asia WGS
AF:
0.175
AC:
607
AN:
3478
EpiCase
AF:
0.141
EpiControl
AF:
0.146

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 07, 2016- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 28, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 21, 2018- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.23
CADD
Benign
6.5
DANN
Benign
0.92

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3798756; hg19: chr6-152529260; COSMIC: COSV54934977; API